FierceBiotech

First look at Pfizer/BioNTech COVID-19 vaccine data in kids aged 5 to 11

Pfizer plans to seek FDA nod for COVID-19 shot in kids 5 to 11 after positive data Pfizer and BioNTech reported that their COVID-19 vaccine is safe and generated a strong response in kids aged 5 to 11. The smaller dosage shot (10 micrograms) provided comparable antibody responses the the 30 microgram dose given to 16- to 25-year-olds. The companies will apply for EUA "as soon as p...

Gilead warns of counterfeit versions of its popular HIV drugs Biktarvy and Descovy circulating at U.S pharmacies.

Gilead cracks down on fake versions of popular HIV drugs Biktarvy, Descovy being sold at US pharmacies Counterfeit versions of two of Gilead Sciences’ most popular HIV drugs, Biktarvy and Descovy, are circulating in the U.S., threatening the health of people taking them, the company warned.

Astronauts has performed the first successful CRISPR/Cas9 gene editing in space.

Astronauts perform first CRISPR gene-editing studies in space Aboard the International Space Station, astronauts used CRISPR to help zero in on how cells repair DNA that may be damaged by cosmic radiation.

In latest drug repurposing for COVID-19, scientists at University of Cambridge suggest antimalarial therapy proguanil and rheumatoid arthritis medication sulfasalazine could be potential candidates for the disease.

Cambridge researchers pinpoint antimalarial, arthritis drugs for COVID-19 repurposing By using computational analyses, scientists at the University of Cambridge have identified 200 approved drugs as possible candidates for repurposing against COVID-19 and validated two of them in early tests. Given that both drugs are well-established, they should be rapidly advanced into clinical tr...